Sammann Derek

CME Group Sr MD sells 7,200 shares for $1,984,798.26 at $275.67 avg, cutting holdings by 50.6%

Sammann Derek, Senior Managing Director of Global Head Commodities Markets at CME Group, executed two separate sales on 2025-11-20 totaling 7,200 shares for $1,984,798.26 at a blended average price of $275.67, reducing his post-transaction holdings from 14,222 shares to 7,022 shares. This represents a substantial reduction of 50.6% of his pre-transaction position. At the current price of $273.09, the executed sales are marginally above current levels, though notably closer to the 52-week high of $290.71 than the low of $225.82. His prior sales at CME (2 measurable outcomes from 2025-05-05) produced flat to slightly positive 90-day returns, with a 0.00% well-timed rate at the 90-day mark across both sales, suggesting this insider's sells at this ticker have not consistently preceded stock declines. CME's fundamentals remain solid with revenue of $1,537,600,000.00, net income of $908,000,000.00, and annual revenue growth of +9.9%, alongside a low P/E of 5.10.

CME Sr MD Sammann sold 4,650 shares for $1,304,847.42 on 2025-05-05 near 52-week highs; 3 prior sells at CME were 100% well-timed

Sammann Derek sold 4,650 shares across 2 separate transactions on 2025-05-05 at a blended average price of $280.61, reducing his CME holdings from 12,986 to 8,336 shares (a -35.8% reduction). The sales occurred at a price very near CME's current $284.82 level, which matches the stock's 52-week high of $284.82, and 30-day and 90-day returns show the stock up +12.9% and +16.5% respectively in the recent window. His prior 3 sales at CME all exhibited negative 90-day returns (well-timed sell pattern at 100% rate), suggesting a consistent ability to exit positions ahead of subsequent weakness. The company's fundamentals remain solid with a P/E of 5.32, latest-quarter revenue of $1,642,300,000.00, and annual revenue growth of +9.9%, providing context that this sale occurs in a strong valuation and operational environment rather than amid deteriorating business conditions.